Centene Corporation $CNC Shares Sold by Aberdeen Group plc

Aberdeen Group plc lessened its position in Centene Corporation (NYSE:CNC) by 15.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 301,993 shares of the company’s stock after selling 54,778 shares during the period. Aberdeen Group plc owned approximately 0.06% of Centene worth $10,633,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Baird Financial Group Inc. bought a new position in Centene in the 1st quarter worth approximately $236,000. Sivia Capital Partners LLC boosted its position in Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after acquiring an additional 4,315 shares during the period. International Assets Investment Management LLC acquired a new position in shares of Centene during the second quarter valued at $410,000. Ethic Inc. raised its stake in shares of Centene by 7.7% during the second quarter. Ethic Inc. now owns 68,384 shares of the company’s stock valued at $3,692,000 after purchasing an additional 4,867 shares in the last quarter. Finally, Forum Financial Management LP lifted its holdings in Centene by 15.4% in the second quarter. Forum Financial Management LP now owns 8,791 shares of the company’s stock worth $477,000 after purchasing an additional 1,172 shares during the period. Institutional investors own 93.63% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CNC. Robert W. Baird upped their price target on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. UBS Group set a $42.00 price target on Centene and gave the company a “neutral” rating in a research note on Thursday, October 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research note on Wednesday, January 21st. Barclays set a $44.00 target price on Centene and gave the company an “equal weight” rating in a research note on Tuesday, November 4th. Finally, Wells Fargo & Company set a $44.00 price target on shares of Centene and gave the company an “equal weight” rating in a report on Wednesday. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $41.88.

Centene Stock Performance

CNC stock opened at $43.61 on Friday. The firm has a market cap of $21.45 billion, a price-to-earnings ratio of -3.20, a PEG ratio of 0.95 and a beta of 0.48. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a quick ratio of 1.08, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. The business’s fifty day simple moving average is $42.39 and its two-hundred day simple moving average is $36.75.

Centene (NYSE:CNC) last posted its quarterly earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.03. The company had revenue of $49.73 billion for the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm’s revenue was up 21.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.